Euro Elite: Russia and CIS – Bear necessities

Euro Elite: Russia and CIS – Bear necessities

The Covid-19 pandemic hit the Russian Federation particularly hard, with the country repeatedly topping all lists for its highest numbers of reported coronavirus cases in Europe. The consequences for the Russian economy were almost instant, with local unemployment rates climbing quickly and consumption rates declining early in the spring of 2020. Naturally, the legal market was also affected by all this.

At the time, both Russian and international law firms had something in common: they were quick to react to the pandemic, closing offices and adjusting successfully to working remotely. Not only did the legal market do its best to contain the impact of the pandemic among its employees and clients – eventually, it played an active part in combating its spread. Continue reading “Euro Elite: Russia and CIS – Bear necessities”

Euro Elite: Southern Europe – Sole resistance

Euro Elite: Southern Europe – Sole resistance

The Eastern Mediterranean countries featured in the Euro Elite – namely Greece, Turkey and Israel – occupy a region where, for one reason or another, international law firms largely refrain from active participation in the local legal markets; leaving a void for high-end, international expertise, willingly filled by domestic, independent firms.

In Israel, international law firms were not permitted to operate in the nation until an amendment made to the Israel Bar Association Law in August 2012. Understandably, eight years is not sufficient time for the foundations of the legal market to drastically shift meaning that very few international firms have any form of presence in the nation. Those that do only have a handful of on-the-ground lawyers between them. Continue reading “Euro Elite: Southern Europe – Sole resistance”

Euro Elite: Switzerland – Locked down

Euro Elite: Switzerland – Locked down

In a space of only 41,285 km², Switzerland has two major language areas and 26 cantons, giving it a fairly unique set-up. Known to be one of the richest countries in the world, it had little problem absorbing the impacts of the Covid-19 pandemic thanks to its stable economy. However, ‘the government hasn’t been very successful at combating the virus’, says Daniel Hochstrasser, senior partner and chair of Bär & Karrer, referring to the country’s at times high numbers of cases and deaths. ‘But that has not changed much in the overall assessment of Switzerland on a global scale.’

With high activity in the industrial, manufacturing and financial services sectors, Bär & Karrer can look back on a successful 2020 overall. ‘The effects were less pronounced than we anticipated when we drew up contingency plans in March,’ says Hochstrasser. ‘In the end, we fortunately didn’t have to take any of those measures’. A highlight for the firm was advising Libra Association on its bid to build a global payment system based on the Libra blockchain; a matter that combined expertise from its banking and finance, fintech and tax departments. Continue reading “Euro Elite: Switzerland – Locked down”

The Euro Elite: Methodology

The Euro Elite: Methodology

Legal Business’ Euro Elite comprises independent law firms based in more than 40 European jurisdictions, rather than branches of international firms or Vereins.

To compile the 100 firms featured in this report, we used a scoring system based on the rankings of firms in the 2020 edition of The Legal 500 EMEA. Points were allocated for firms ranked in tiers 1-3 in tables featured in the guide. Top-tier rankings earned three points, second tier two and third one point. Continue reading “The Euro Elite: Methodology”

Sponsored briefing: Life sciences market in France: Early access of medicines reform for 2021

Sponsored briefing: Life sciences market in France: Early access of medicines reform for 2021

LexCase’s Diane Bandon-Tourret and Esther Vogel on the newly restructured early access mechanism for medicine products in France

The French Social Security Financing Law (LFSS) for 2021 restructured the entire early access mechanism for medicine products. Continue reading “Sponsored briefing: Life sciences market in France: Early access of medicines reform for 2021”

Sponsored briefing: Brexit places the UK out of the judicial cooperation area in the EU; will this be the end of English law in the continent?

English law, courts and lawyers are a popular option for business transactions in the EU. Brexit could possibly change that, not so much because of obstacles to a valid choice of English law or the enforceability of judgments rendered by English courts but because the UK is now outside the many procedures for judicial cooperation within the EU (summoning, taking of evidence and other forms of judicial cooperation) which are vital for effective cross-border litigation.

The legal life cycle

Continental firms often have their commercial and financial agreements governed by English law even if none of the parties are domiciled in England. This contractual choice of applicable law is invariably combined with a choice of English courts to hear any dispute. While the UK was an EU member state both choices were expressly admitted as valid and enforceable as a matter of EU law under well-known regulations. Continue reading “Sponsored briefing: Brexit places the UK out of the judicial cooperation area in the EU; will this be the end of English law in the continent?”

Sponsored briefing: Ukraine – successful heir of the Soviet empire or a self-made kid on the block?

Sponsored briefing: Ukraine – successful heir of the Soviet empire or a self-made kid on the block?

Being one of the most powerful industrial countries of the former USSR with a unique geographic location and the biggest territory in the heart of Europe, stretching from Europe in the West towards Russia in the East, Ukraine has entered the independence era with high expectations and significant industrial and scientific potential.

A robust logistics network, including a web of railway, connecting the most remote parts of the country, seaports, energy (including hydro and nuclear), unique defence and air-space companies, large agricultural companies – these are just a few sectors to mention, which have decisively shaped the future of the Ukrainian economy. Continue reading “Sponsored briefing: Ukraine – successful heir of the Soviet empire or a self-made kid on the block?”

Sponsored practice area spotlight: Tax: Standardisation of the practice of employee benefit plans in Switzerland

Sponsored practice area spotlight: Tax: Standardisation of the practice of employee benefit plans in Switzerland

Since 1 January 2021 three significant changes have been in effect in relation to the practice regarding the Swiss tax treatment of employee benefit plans. The Swiss Federal Tax Administration stipulated this practice update in its circular letter No. 37 on employee benefit plans.

In the absence of a fair market value, the corporate valuation must be carried out using a suitable and recognised method and the (tax-relevant) fair market value can be determined in the same way as for wealth tax purposes

As from 1 January 2021, non-listed companies implementing an employee benefit plan will be valued based on the so-called practitioner method ((2x earnings value + 1x net asset value) divided by 3). Depending on the canton, other assessment approaches may also be applicable for companies that meet the qualifications of start-ups. Irrespective of this change in practice, companies can still apply a valuation using their own methodology (eg an EBITDA multiple), provided that (i) the formula plausibly reflects the business model, (ii) it is comprehensible and (iii) it is accepted in advance by the relevant cantonal tax authorities as ‘suitable and approved’. It is advisable to ensure the acceptance of a separate valuation formula by means of an advance tax ruling.

National-wide possibility of a tax-free capital gain after a five-year holding period

As a general rule, both the purchase of employee participations may be subject to Swiss individual income tax. That is, the difference between both the purchase price paid by the employee (if any) and the fair market value constitutes an employee-related benefit and is subject to tax. The same applies, if there is a surplus profit in the event of a sale; ie if the sale price exceeds the value of the employee participation based on the same formula as at the time of allocation and the sales price. The surplus benefit is generally treated as taxable employment related benefit. However, as of 1 January 2021, a holding period applies to the taxation of this surplus benefit:

What previously applied only in the Canton of Zurich now (since 1 January 2021) applies throughout Switzerland. After a five-year holding period, any surplus profit will no longer be subject to Swiss individual income tax. Thus, the entire difference between the value at the time of granting the shares and the latter sales price qualifies as a tax-free capital gain, save for income taxation of violations of an eventual blocking-period in years n6-n10.

This tax exemption for capital gains in principle only applies for sales to third parties. The five-year holding period remains irrelevant for re-sales to the company or its shareholders, and any surplus profit is subject to income tax and social security contributions in the cantons in question.

The change of practice will undoubtedly apply to new employee benefit plans throughout Switzerland. In a perfect world, the same rules should also be applicable to existing employee benefit plans, where employee participations were allocated before 2021. Unfortunately – as a result of the Swiss federal system – this is not (yet) the case. Depending on the canton, there are currently different opinions as to how the new nationally applicable five-year holding period shall apply to existing employee benefit plans. Companies affected will most likely not be able to avoid getting in touch with the relevant cantonal tax authorities to resolve this ambiguity and to be on the safe side.

Shares acquired at third-party conditions or subscribed for during incorporation do not qualify as employee shares

If employees acquire shares of the company at the same terms and conditions as those applicable to third-party investors, their shares do not qualify as employee shares. The same applies to shares acquired by shareholders (so-called ‘founding shareholders’) in the course of the incorporation of the company. Future capital gains realised on such sales are therefore entirely tax-free, irrespective of whether the sale is made to third parties, to the company or to shareholders. However, this requires that no discount due to the blocking period is granted when allocating the shares.

However, other aspects of the tax authorities’ intervention against the tax-free capital gain, such as the qualification of the shares as business assets or the qualification of the employee or founding shareholder as a professional securities dealer, must be considered.

The changes of the practice are highly welcomed. Nevertheless, the effects on existing employee share plans are ambiguous owing to the lack of clear transitional provisions. It is therefore worthwhile for affected employees and employers to consult their tax adviser as early as possible.

FOR MORE INFORMATION

To find out more about Prager Dreifuss’ tax team, contact Lukas Scherer, tax counsel

T: +41 44 254 55 55

E: lukas.scherer@prager-dreifuss.com

Sponsored briefing: The Impact of Covid-19

Sponsored briefing: The Impact of Covid-19

EBN & Co’s Viva Gayer and Jonathan Achiron on the impact coronavirus has had on the M&A sector and what the future may hold for such transactions

The Covid-19 pandemic will continue to affect the world economy. Covid-19 has put nearly every aspect of business operation to a test. We have seen a slow-down in the number and scope of M&A transactions in the first and second quarters of 2020. Whereas 2019 was phenomenal for the Israeli M&A market, it is clear that 2020 and even 2021 will be challenging. The M&A market will need to re-invent itself. Continue reading “Sponsored briefing: The Impact of Covid-19”